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Abstract
Background: A comprehensive in-hospital patient management with reasonable and economic resource allocation is
arguably the major challenge of health-care systems worldwide, especially in elderly, frail, and polymorbid patients. The
need for patient management tools to improve the transition process and allocation of health care resources in routine
clinical care particularly for the inpatient setting is obvious. To address these issues, a large prospective trial is warranted.
Methods: The “Integrative Hospital Treatment in Older patients to benchmark and improve Outcome and Length of stay”
(In-HospiTOOL) study is an investigator-initiated, multicenter effectiveness trial to compare the effects of a novel in-
hospital management tool on length of hospital stay, readmission rate, quality of care, and other clinical outcomes using
a time-series model. The study aims to include approximately 35`000 polymorbid medical patients over an 18-month
period, divided in an observation, implementation, and intervention phase. Detailed data on treatment and outcome of
polymorbid medical patients during the in-hospital stay and after 30 days will be gathered to investigate differences in
resource use, inter-professional collaborations and to establish representative benchmarking data to promote
measurement and display of quality of care data across seven Swiss hospitals. The trial will inform whether the “In-
HospiTOOL” optimizes inter-professional collaboration and thereby reduces length of hospital stay without harming
subjective and objective patient-oriented outcome markers.
Discussion: Many of the current quality-mirroring tools do not reflect the real need and use of resources, especially in
polymorbid and elderly patients. In addition, a validated tool for optimization of patient transition and discharge
processes is still missing. The proposed multicenter effectiveness trial has potential to improve interprofessional
collaboration and optimizes resource allocation from hospital admission to discharge. The results will enable inter-hospital
comparison of transition processes and accomplish a benchmarking for inpatient care quality.
Keywords: Health services research, Integrated care, Interprofessional, Polymorbidity, Transition, Discharge planning,
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Background
One of the major challenges of health-care systems,
governments, and societies worldwide is a comprehen-
sive in-hospital patient management with reasonable and
economic resource allocation [1], especially in frail, poly-
morbid, and elderly patients. A lower level of education
and a cognitive impairment are additional risk factors.
[2]. Novel and optimized diagnostic and therapeutic ap-
proaches have increased expectation of life, resulting in
increased polymorbidity and complexity. Moreover,
elderly patients with high demands for medical, but also
nursing and social care call for a tighter allocation of our
health care resources [3, 4]. Whereas emergency hospitali-
zations are facilitated by chronic disease burden, co-mor-
bidities, and frailty, the trigger for hospital admission is
often a per se minor acute event (e.g. urinary tract infec-
tion), disrupting the fragile bio-psycho-social homeostasis
of polymorbidity. In many cases, a post-acute transfer to a
nursing care facility is required. The need for patient man-
agement tools to improve the transition process and alloca-
tion of health care resources in routine clinical care
particularly for the inpatient setting is obvious.
Challenges and current evidence
Misutilization and suboptimal resource allocation chal-
lenges safe and efficient, patient-centered in-hospital
transition from the emergency department (ED) to a
medical ward, and transition to home or post-acute care
facilities [5]. Errors that lead to unplanned readmissions
and preventable deaths are more common in polymor-
bid patients [6]. Since the majority of medical inpa-
tients with chronic illnesses become hospitalized via
ED (non-electively), optimized resource use must start
at the ED with an improved triage.
The optimal organization of routine medical ward care
in mostly polymorbid, elderly medical patients received
less alertness than the handling of specific diseases.
Specifically, there is a lack of large trials focusing on
polymorbid patients and their objective outcomes [7].
The inter-professional team care approach with a com-
prehensive geriatric in-hospital assessment has been
found effective to increase patients’ likelihood of being
alive and living in their own homes after an emergency
admission to hospital [8]. Conversely, many earlier studies
were unable to link interdisciplinary team care interven-
tions to affect existing metrics, partly because of limited
methodology and outcome measures [9]. As recently
shown in a review article, several innovative interprofes-
sional and interdisciplinary healthcare interventions on
medical wards usually have chosen length of hospital stay,
mortality rates, readmission, or functionality as their pri-
mary outcome measures [10]. However, most interven-
tions have not shown any effect on these patient-oriented
outcomes and are therefore debatable and inconsistent.
Few evidence suggests that an improved interprofessional
collaboration would reduce adverse effects of care. Thus, a
significant reduction in length of hospital stay have been
reported due to contemporaneous secular reasons [11],
which most of the published interventions did not reduce
additionally. The majority of inpatient setting interven-
tions were unlikely to reduce readmissions, neither to re-
duce mortality rates, nor to diminish need for nursing
facilities after discharge. However, generalizability of these
findings remains weak due to discrepancies between dif-
ferent healthcare systems and heterogeneous (inter-)-
national standards of care.
Recently, innovative strategies to synergize the concepts
of implementation science, precision medicine, and learn-
ing health care systems have been advocated [12]. Using
this experience, we will integrate evidence-based strategies
(e.g., training, supervision, quality monitoring tools, sys-
tem change interventions) into real-world practice [13].
Rationale of the study and overall aim
The main reason for the large controversy of the differ-
ent tool’s effectiveness in elderly, polymorbid patients is
mainly explained by the current lack of evidence. Hence,
a large prospective multicenter trial is warranted to in-
vestigate the effects of a patient in-hospital management
tool (“In-HospiTOOL”). Using an interrupted time series
(ITS) model to gather detailed treatment and outcome
data of elderly, polymorbid medical patients during the
in-hospital stay and 30 days after admission, we will in-
vestigate differences in resource use (Module 1), inter-
professional collaborations (Module 2), and establish a
representative benchmarking database to promote meas-
urement and display of quality of care [14] across differ-
ent sized Swiss hospitals (Module 3).
Methods/design
Aim and study design
The “In-HospiTOOL” study is a quasi-experimental
investigator-initiated, multicenter effectiveness trial inves-
tigating the effects of a new patient in-hospital manage-
ment tool to improve length of hospital stay and other
outcomes using an ITS model. The overall 18-month
study time is divided in a 6-month observational phase,
a 6-month implementation phase, and a 6-month inter-
vention phase.
Setting, study sites and characteristics of participants
The multicenter trial includes seven secondary and tertiary
care hospitals within Northern Switzerland. This allows to
collect representative nation-wide patient-oriented data
from polymorbid patients. All senior executive leaders have
reassured full support for an optimal implementation of
the “In-HospiTOOL” in their hospitals. Upon hospital
admission, consecutive adult (age ≥ 18 years), polymorbid
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(> 1 diagnose) medical inpatients will be included in our
study. Except for non-medical and non-adult patients there
will be no exclusion criteria.
Patient population
Intervention population
To reflect “daily practice”, we include consecutive
adult medical inpatients independent of their diagno-
sis during the observation, implementation, and inter-
vention period, respectively, into the analysis - like an
intention-to-treat approach.
Control population
For our statistical approach as outlined below, we re-
quest data from the Federal Statistical Office to provide
a nationwide comparability. We will use data on length
of hospital stay. Age, gender, health care insurance, place
of residence, main diagnosis, comorbidities, and study
center will be used for statistical adjustment.
Data collection process
The study period is divided into three 6-month phases,
whereas the observation and the intervention phase until
the end of January 2019 are season-matched, interrupted
by a run-in non-season-matched implementation phase.
The period of “In-HospiTOOL” implementation in the
participating hospitals will be devoted to technical im-
plementation, training of involved study personnel,
nurses, social workers, physicians, and pilot testing. We
will collect data throughout all three study periods by
using electronic medical records and will contact all pa-
tients 30 days after hospital admission by phone interview.
Data from the structured phone interviews will be stored
on a data base using the secuTrial© software (secuTrial®;
interActive Systems GmbH, Berlin, Germany).
Theoretical aspects, hypothesis
Module 1 resource (mis-)utilization & allocation
We hypothesize that implementing the “In-Hospi-
TOOL” in a nationwide multicenter setting will sig-
nificantly shorten length of hospital stay without
compromising patient outcomes and functional inde-
pendence. Systematic early determination of clinical
stability, estimation of the post-acute care referral
probability (using the Post-acute care discharge [PACD]
score [15]), fixing a possible discharge date after initial ED
assessment as well as a tight interprofessional collabor-
ation enabled through an electronical communication
platform (“Visitentool”, Fig. 1) will result in decreased
waiting times contributing to the shortening of length of
hospital stay [16–18].
Module 2 Interprofessional collaboration, integral hospital
and post-acute patient transition
Transparent and systematic interprofessional communi-
cation will reveal factors for delay in these polymorbid
patients (pending diagnostics, medical treatments, ad-
ministrative and organizational elements) throughout
the hospital stay. Doing so, we will identify regional and
socioeconomic (e.g., health care insurance status) differ-
ences in the patient care continuum. We hypothesize
that longitudinal observation of patient transition will
further allow measurement of effective time from initial
request to a post-acute care institution to effective trans-
fer with corresponding internal and external delaying
factors (Fig. 2). We will systematically examine patient
satisfaction, hypothesizing that it will not decrease upon
the study intervention. Implementing a reengineered
discharge questionnaire including the teach-back meth-
odology, we aim to improve patient education [19, 20].
This effort will not only strengthen interprofessional
coordination and communication, but also increase
health care continuity across all hospital transition
steps. Moreover, we systematically investigate reasons
for low satisfaction.
Module 3 benchmarking to advice health care authorities
and stakeholders
The buildup of a large dataset including comprehensive pa-
tient information (demographics, clinical, organizational,
health insurance status) will be a basis for future data shar-
ing in Switzerland [21]. We hypothesize that this dataset
from several hospitals will allow to identify associations of
management factors and outcome data, thereby facilitating
a better understanding how interventions affect patient
outcomes. Convocation of a multi-professional sounding
board with tailored implementation interventions [22] will
be inevitable to built-up a data warehouse and thus, broad
dissemination of our results with potential to improve
health care service also in non-participating health care
institutions.
Endpoints
All patients will be daily assessed during hospitalization
and contacted 30 days after admission by phone for a
structured and blinded interview to assess primary and
secondary endpoints.
The primary endpoint of this study is length of hos-
pital stay within 30 days after admission including
readmissions during this period (corresponding to
Module 1). Length of hospital stay will be verified
based on hospital data for the index hospital stay and
complemented by 30-day interviews regarding possible
secondary hospitalizations.
Secondary endpoints (corresponding to Module 1–3)
include measures of patient-oriented outcomes:
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a) in-hospital and all-cause 30-day mortality
b) unplanned readmissions or unplanned general
practitioner / ED visits
c) delaying factors of ED- and medical ward’s flow
d) effective time to hospital discharge after involving
external institutions (time from transfer application
to transfer)
e) institutionalization
f ) satisfaction with ED-, ward-, and discharge process
g) functional status (incl. Quality of life) using the
EuroQol Group 5-Dimension Self-Report
Questionnaire (see Additional file 1) [23].
To study hospital internal processes and effects of
interprofessionality, we will look at compliance and
agreement of the three health professions (physicians,
nursing, and social workers) in the use of “In-Hospi-
TOOL”, and delays from the anticipated to the effect-
ive discharge date as compared to discharge date
anticipated by the different health care professionals
on admission and during the course of the hospital
stay. We will use the above-mentioned outcome data
set as benchmark to establish a risk-adjusted resource
and quality cockpit to compare different hospitals and
demographics (corresponding to Module 3).
Independent variables
The primary exposure variable of interest is the interven-
tion, i.e. the implementation of the “In-HospiTOOL”. As
outlined in the statistical plan, we will adjust our model to
the following covariates: demographics (age, gender, health
care insurance, home of residence [home versus facility]),
Fig. 1 The “Visitentool” (german for “ward-round tool”). Inter-professional collaboration via an electronical communication platform. Nursing and
physician staff as well as social services daily assess the clinical and functional situation about possible discharge (using simple, intuitive color coding)
and propose possible discharge dates. Also, reasons for delays in discharge are being monitored
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main diagnosis (grouped using the “International Classifi-
cation of Diseases (ICD-10)” [24]), comorbidities (using the
Elixhauser comorbidity index [19]), and study center.
Implementation strategies and components
Electronical tools
Based on a sounding board discussion, we designed and
optimized the different electronical study tools in collab-
oration with the technical providers. In addition, we
defined and implemented a structured data export, first,
to guarantee user’s compliance measurement during study
time, second, to enable adoption of tool items during the
implementation period based on preliminary analyses,
and, third, to establish a patient-oriented data “cockpit”
for benchmarking.
User-oriented key data benchmarking
Based on the sounding board consensus, we designed a
structured questionnaire (see Additional file 2) to per-
form phone interviews with all included patients 30 days
after hospital admission to assess their outcome data
and satisfaction. Each study site establishes a local inter-
view team performing the 30-day structured follow-up
interviews. Depending on the cumulative number of pa-
tients, between 3 and 7 part-time working persons were
recruited by each study site, respectively, and were fi-
nally instructed by the core study nurse team.
Coaching
Before starting the implementation phase, a minimum of
two interprofessional onsite visits at each study site en-
sures full information and compliance of the local staff
(physicians, nurses, social workers, therapeutic disci-
plines) about participating in the In-HospiTOOL study
and preparing them how to use the newly designed elec-
tronical study tools in the later implementation phase.
Before and during the intervention phase, a minimum of
two interprofessional onsite visits at each study site will
be repeated to guarantee an optimal monitoring quality
and a high usability. To guarantee a standardized staff
education, we designed (in cooperation with the “Berner
Bildungszentrum Pflege”) and provide a teaching video
to all study sites, where the appropriate usage of the
electronical study tools has been described comprehen-
sively (https://youtu.be/bNyRPucs-FQ). To finally guar-
antee a maximal utilization and a correct application in
daily clinical routine, we encourage all the study sites to
introduce a local supervisor. The local supervisor will
monitor compliance of the In-HospiTOOL usage, such as
the physician’s initial assessment, PACD score, Visitentool
Fig. 2 The “In-HospiTOOL”. An integrative patient management tool. The “In-HospiTOOL” has three components involving admission (inter-
professional initial assessment, “Ersterfassung”), medical ward (inter-professional daily re-assessment, “Visitentool”), and discharge (inter-professional
patient education, reengineered discharge [32]). PACD, Post-Acute Care Discharge [15, 18]
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(on weekdays), reengineered discharge form, and inter-
venes if appropriate. The required profiles of personnel
qualification are assertiveness and well-experienced clin-
ical nurses, nursing experts with clinical background, or
case managers.
Statistical analysis plan and sample size
The primary analysis population includes all consecutively
recruited patients following an intention-to treat (ITT)
principle. The number of patients lost to follow-up will be
minimized by every effort. The per-protocol (PP) popula-
tion analysis will be prospectively defined to exclude pa-
tients in whom major protocol violations have occurred.
Specifically, the following criteria will lead to exclusion
from the PP population: major violation of study inclusion
or study exclusion criteria, patients with missing informa-
tion from the In-HospiTOOL forms, or missing follow-up
interviews.
We will compare all endpoints between all three study
phases in the overall ITT population, the PP population
and within predefined subgroups as discussed below. We
will analyze all endpoints in an adjusted manner for the
main covariates such as age, gender, health care insurance,
home of residence, main diagnosis, comorbidities, and
study center. Regarding sample size considerations, we
include consecutive patients in each hospital over a
6-month period for the observation, implementation, and
the intervention period, respectively. Given the large num-
ber of patients per study site seen in routine (i.e. between
2`500 and 8`000 polymorbid medical inpatients) per year,
we estimate to enroll approximately ~ 35′000 patients
over 18months of recruitment. This large amount of
patient data will provide adequate power to investigate the
effect of introducing a patient care tool in the overall
medical hospitalized patient population and allow for sub-
group analyses, as well as important post-hoc analyses.
We will perform two complementary, quasi-experimental
analyses to estimate the effect of the intervention: difference
in differences and ITS.
Difference in differences
To quantify an overall effect on length of hospital stay
after implementing the “In-HospiTOOL”, we fit a
patient-level multivariate linear regression model. It will
include lengths of hospital stay of “control” hospitals, all
risk adjusters listed above in the manuscript, and a time
variable for study weeks. The dependent variable will be
length of hospital stay (days in hospital). We will test for
interaction between the intervention period and the
intervention population and will assess whether there is
a difference in the change (slope) in length of hospital
stay over time between the two study populations. The
intervention and control groups will have different base-
line characteristics, however both groups will be exposed
to similar alterations in outcomes over time without the
interventional program.
Interrupted time series (ITS) model
We will analyze the trends in length of hospital stay
from start of observation through the end of the inter-
vention period (18 months). For this purpose, we will
conduct an ITS as a sensitivity analysis. We will imple-
ment the ITS using generalized estimating equations
(GEE), to examine linear trends in weekly, hospital-level,
risk-adjusted length of hospital stays. ITS models will be
tested for autocorrelation to control for seasonal trends
using the Durbin-Watson statistics [25]. We will analyze
the change in trend between all three time periods. This
approach allows us to distinguish between a possible ef-
fect of the intervention and a difference from underlying
trends facing both study groups and can also help to
analyse whether the intervention effects will sustain over
time. We will calculate weekly-adjusted length of hos-
pital stay using linear GEE that includes all lengths of
hospital stay from the control and intervention popula-
tions and all above mentioned risk factors. We will
graph weekly length of hospital stay for all populations
over time and use the estimated weekly means for con-
trol and intervention patients to assess for a weekly
difference between the two groups. Finally, we explore
whether the adjusted weekly length of hospital stay de-
creases in the intervention period and whether there will
be an independent time trend effect induced by the
intervention only [26].
To summarize, we will use four statistically hypothesis
tests during each period: (i) Are there significant trends
in length of hospital stay change during the period. (ii)
Will the trend differ between the control and interven-
tion populations (the interaction between time and con-
trol or intervention conditions) during the period. (iii)
Will the trend during the intervention period differ from
the trend during the observation period within all three
conditions. (iiii) Will the magnitude of the altered trend
between the intervention and the observation period
differ between the three conditions (the interaction be-
tween the change in slope and intervention or control
conditions). These models will also be implemented for
the analyses of the secondary endpoints.
Discussion
Scientific significance
Performing clinical trials in the usual care setting
(“comprehensive effectiveness health services research”)
has the potential to identify and demonstrate relevant
patient-oriented outcomes to the institutions where
they are performed and at the same time to yield infor-
mation that may be generalizable to the health care
system at large [27].
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Health care spending in Switzerland is among the
highest worldwide and has been rising due to a change
in demographics. Still, a high scientific evidence regard-
ing performance, safety, and cost-effectiveness of specific
integrative multi-professional care models tailored to the
Swiss health care system is largely lacking. The “In-Hos-
piTOOL” is an electronic integrative multi-professional
inpatient management tool to better understand the var-
iegated health care processes. Using a standardized but
also personalized procedure, the In-HospiTOOL will
optimize the interprofessional management of polymor-
bid acutely-ill patients from ED admission to hospital
discharge. Herewith, we will improve transparency, re-
source use, patient outcomes, patient satisfaction, and
functional status. An overall cost-effectiveness analysis
will be performed separately as a secondary analysis. We
anticipate that the results of the In-HospiTOOL-study
will contribute to improved (inter-)national inpatient
health care and reduce overall costs.
In addition to the main interventional trial, gathering
of data from around 35`000 polymorbid patients from
seven Swiss hospitals will help to establish a nationwide
framework involving important stakeholders of the Swiss
health care system. Interprofessional and interdisciplin-
ary collaboration are prerequisites for an improved sus-
tainable patient-oriented health care delivery with an
optimal resource allocation. This will lead to a more effi-
cient patient transition with decreased risk for hospital
associated adverse outcomes. Besides, the large dataset
will allow the comparison of different outcomes of dif-
ferent patient populations across different hospitals with
each individual health care strategies. In addition, health
insurances and policy authorities might profit from these
data to conceptualize new reimbursement strategies in
the polymorbid inpatient setting.
Such integrated comparative effectiveness health ser-
vices research relies on the collaboration of care providers
and health care systems as active partners in defining the
objectives of the research rather than as passive con-
sumers of its product [27]. This pragmatic study will
hopefully enforce a change in “culture” by rethinking and
redefining traditional regulatory and ethical standards (e.g.
patient informed consent and overall engagement in re-
search) in this paradigm of low risk research [28].
As the evidence about interventions for optimization
of in-hospital patient transition is scarce, some hospitals
have designed their own tools. However, performance,
cost- effectiveness, safety, transferability, and external
validity of these interventions are poorly investigated
[29, 30]. Different health care stakeholders lack scientific
evidence to support and authorize changes or to im-
prove transition of polymorbid patients. Thus, a further
validation of interprofessional interventions and quality
benchmarks is urgently needed to close this gap in current
health care discussions. Patient management, transition
and length of hospital stay without negatively affecting
patient outcomes and functional independence despite
polymorbidity should be of highest relevance in this
real-world and pragmatic multicenter setting [10, 31].
Our study has several potential limitations. First, inclu-
sion of about 35`000 patients over the 18-month study
time frame is ambitious. However, based on our large ex-
perience from previous multicenter studies, a well-estab-
lished multicenter research network, and the high
prevalence of hospitalized multimorbid patients eligible
for this trial, we are convinced that the trial is feasible.
The second limitation of this trial is the lack of
randomization. Methodologically, in a trial whose inter-
vention focuses on the process of care, neither patient-
level randomization nor a randomized cross-over design
was feasible as a carry-over effect would have biased the
control group. For a cluster randomized trial, a large num-
ber of similar clusters (i.e. hospitals) would be needed –
which is challenging in Switzerland particularly in light of
the limited study budget. Therefore, we chose an ITS
model in a quasi-experimental study design using admin-
istrative data from non-participating hospitals as a control
group. Doing so, we account for differences in the patient
population that may occur due to epidemiological varia-
tions. Third, as a pragmatic trial with a bundled interven-
tion, it will be challenging to understand which part of
our intervention shows clinical effects, leading to potential
participation bias. Nonetheless, the large amount of health
care data collected will also allow to provide scientific evi-
dence as to which elements of patient management are
influenced by the intervention.
In conclusion, this pragmatic comparative effectiveness
health services research trial will inform whether the
implementation of a novel electronic tool for inpatient man-
agement optimizes inter-professional collaboration and
thereby reduces length of hospital stay without derogating
subjective and objective patient-oriented measures. Our trial
will help to compare between diverse transition processes
within seven different hospitals and to create a benchmark-
ing for inpatient care quality. This study synergizes national
networks and, thus, has the potential to become a corner-
stone in the present public healthcare discussion.
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